Baluch W M
Group Health Cooperative of Puget Sound, Renton, WA 98057, USA.
Am J Health Syst Pharm. 1995 Feb 1;52(3):287-93. doi: 10.1093/ajhp/52.3.287.
A comprehensive smoking-cessation program sponsored by a health maintenance organization (HMO) and the role of pharmacists in the program are described. Group Health Cooperative of Puget Sound is an HMO serving more than 385,000 enrollees in western Washington State. Group Health established a smoking-cessation program in 1985. The smoking-cessation benefit consists of interventions by providers to determine smoking status, a formal behavioral modification program, and nicotine-replacement therapy (beginning in 1993) for patients undergoing behavioral modification. The behavioral modification program is offered in group or individualized format. A team of trained nursing, medical, and pharmacy staff members provides consultative support to the program's smoking-cessation specialists. A tobacco-use road-map team has been created as part of the quality-improvement effort at Group Health; a pharmacist serves on this team. The ultimate goal of the team is to reduce the percentage of adult enrollees who smoke from the current 20% to 12.5% by 2000. A procedure for promoting smoking cessation was presented to all the pharmacists, along with continuing-education sessions. The pharmacists are encouraged to be brief but consistent in their antismoking message and to apply the "four A's" (ask about the patient's smoking status, advise the patient to quit smoking, assist in the patient's efforts to quit, and arrange follow-up). The inclusion of nicotine-replacement products in the smoking-cessation program in 1993 provided pharmacists with a key role in determining dosages and monitoring patients. Although the program is leading many smokers to quit, efforts will have to be intensified if program goals are to be realized by 2000.(ABSTRACT TRUNCATED AT 250 WORDS)
本文描述了由一家健康维护组织(HMO)发起的综合戒烟项目以及药剂师在该项目中的作用。普吉特海湾集团健康合作社是一家为华盛顿州西部超过38.5万名参保人服务的HMO。该集团健康合作社于1985年设立了戒烟项目。戒烟福利包括医疗服务人员进行的干预措施,以确定吸烟状况、一个正式的行为矫正项目,以及为正在接受行为矫正的患者提供的尼古丁替代疗法(始于1993年)。行为矫正项目以小组或个性化形式提供。一组经过培训的护理、医疗和药学工作人员为该项目的戒烟专家提供咨询支持。作为集团健康合作社质量改进工作的一部分,成立了一个烟草使用路线图团队;一名药剂师是该团队成员。该团队的最终目标是到2000年将吸烟的成年参保人比例从目前的20%降至12.5%。向所有药剂师介绍了促进戒烟的程序,并举办了继续教育课程。鼓励药剂师在其反吸烟信息中简洁但一致,并应用“四个A”(询问患者的吸烟状况、建议患者戒烟、协助患者戒烟努力以及安排随访)。1993年将尼古丁替代产品纳入戒烟项目,使药剂师在确定剂量和监测患者方面发挥了关键作用。尽管该项目已促使许多吸烟者戒烟,但如果要在2000年实现项目目标,仍需加大努力。(摘要截选至250词)